Medicine and Dentistry
Mastocytosis
100%
Mast Cell
53%
Disease
51%
Systemic Mastocytosis
37%
Diagnosis
35%
Anaphylaxis
35%
Indolent Systemic Mastocytosis
31%
Tryptase
27%
Primary Health Care
20%
Symptom
19%
Clinical Immunology
15%
Food Allergy
14%
Quality of Life
14%
Immunoglobulin E
13%
Skin Defect
12%
General Practitioner
12%
Systematic Review
12%
Allergology
12%
Drug Intolerance
12%
Urticaria Pigmentosa
12%
Cell Activation
11%
Insect Venom
11%
Activation Syndrome
11%
Asthma
11%
Allergic Response
10%
Immunotherapy
9%
Urticaria
8%
Wasp Venom
8%
Placebo
8%
Desensitization
8%
Pediatrics
8%
Overall Survival
7%
Neoplasm
6%
Prevalence
6%
Gene Expression
5%
Adolescent
5%
Acetic Acid
5%
Epinephrine
5%
Eczema
5%
Bone Density
5%
Immunology and Microbiology
Mastocytosis
75%
Food Allergy
42%
Anaphylaxis
40%
Immunotherapy
39%
Allergen Immunotherapy
37%
Mast Cell
35%
Immunoglobulin E
26%
Clinical Immunology
21%
Hymenoptera
20%
Allergen
19%
Grass Pollen
15%
Allergic Asthma
15%
Asthma
15%
Cell Activation
12%
Drug Hypersensitivity
12%
Mouse Model
12%
Vespidae
12%
Gene Expression
10%
Hypersensitive Response
10%
Sublingual Immunotherapy
9%
Gene Expression Profiling
9%
T Cell
8%
Respiratory Tract Allergy
7%
Eczema
6%
Acetic Acid
6%
Prevalence
6%
Sensitization
5%
Histamine
5%
Keyphrases
Mastocytosis
40%
Competence Networks
22%
Food Allergy Quality of Life
21%
Sublingual Immunotherapy
20%
Systemic Mastocytosis
18%
Allergic Diseases
16%
Food Allergy
15%
Mast Cell Activation Syndrome
13%
Meta-analysis
13%
Systematic Meta-analysis
13%
Tryptase
11%
Skin Lesions
9%
Insect Venom Allergy
9%
Academy
8%
Allergic Rhinoconjunctivitis
8%
Grass Pollen
8%
Cutaneous Mastocytosis
8%
Venom Immunotherapy
8%
Anaphylaxis
8%
Health-related Quality of Life
7%
Vitamin D3
7%
Indolent Systemic Mastocytosis
7%
Mast Cells
7%
Adult Form
7%
Allergy Immunology
6%
Clinical Immunology
6%
Adult Patients
6%
Diagnostic Criteria
6%
Mastocytosis in the Skin
6%
Insect Venom
6%
Wasp Venom Allergy
6%
Overall Survival
5%
Bone Marrow
5%
Generic Health-related Quality of Life
5%
Advanced Systemic Mastocytosis
5%
Clinical Impact
5%
